Onychomycosis in Patients with Chronic Leg Ulcer and Toenail Abnormalities

Overview

Journal An Bras Dermatol

Specialty Dermatology

Date 2015 Feb 13

PMID 25672317

Citations 3

Authors

Joana Cabete

Celia Galhardas

Margarida Apetato

Sara Lestre

Affiliations

Soon will be listed here.

Abstract

Nails have a limited number of reactive patterns to disease. Accordingly, toenail changes of different etiologies may mimic onychomycosis. OBJECTIVE To determine the prevalence of toenail onychomycosis among patients with leg ulcer and toenail abnormalities attending a dermatology clinic. METHODS A cross-sectional study was conducted through the analysis of clinical records and results of mycological examination. RESULTS A total of 81 patients were included, with a median age of 76.0 years. Most ulcers were of venous etiology, followed by those of mixed and arterial pathogenesis. The mycological evaluation confirmed the diagnosis of onychomycosis in 27.2% of the patients. The etiologic agent was a dermatophyte in 59.1% of isolates in nail samples, while Trichophyton interdigitale was the most frequent fungal species (40.9%). CONCLUSIONS Most toenail abnormalities in patients with chronic leg ulcer were not onychomycosis. This study highlights the importance of systematic mycological examination in these patients, in order to avoid overtreatment with systemic antifungals, unnecessary costs and side effects.

Citing Articles

Dermatophytes: Update on Clinical Epidemiology and Treatment.

Barac A, Stjepanovic M, Krajisnik S, Stevanovic G, Paglietti B, Milosevic B Mycopathologia. 2024; 189(6):101.

PMID: 39567411 DOI: 10.1007/s11046-024-00909-3.

Prevalence of Onychomycosis in Diabetic Patients: A Case-Control Study Performed at University Hospital Policlinico in Catania.

Trovato L, Calvo M, De Pasquale R, Scalia G, Oliveri S J Fungi (Basel). 2022; 8(9).

PMID: 36135647 PMC: 9500927. DOI: 10.3390/jof8090922.

Prevalence of Onychomycosis among Patients with Transverse Overcurvature of the Nail: Results of a Cross-Sectional Study.

Noriega L, Di Chiacchio N, Borges Figueira de Mello C, Suarez M, Bet D, Di Chiacchio N Skin Appendage Disord. 2020; 6(6):351-354.

PMID: 33313050 PMC: 7706518. DOI: 10.1159/000509985.

References

Saez de Ocariz M, Arenas R . Frequency of toenail onychomycosis in patients with cutaneous manifestations of chronic venous insufficiency. Int J Dermatol. 2001; 40(1):18-25. DOI: 10.1046/j.1365-4362.2001.00181.x. View

Ozkan F, Ozturk P, Ozyurt K, Inci M, Kalender A, Bakan B . Frequency of peripheral arterial disease and venous insufficiency in toenail onychomycosis. J Dermatol. 2012; 40(2):107-10. DOI: 10.1111/1346-8138.12020. View

Binaghi F, Cannas F, Fronteddu P, PITZUS F . [Relation between changes in the microcirculation in the capillaries supplying the toenails and the degree of chronic venous insufficiency]. Minerva Cardioangiol. 1994; 42(4):163-8. View

Baran R, Kaoukhov A . Topical antifungal drugs for the treatment of onychomycosis: an overview of current strategies for monotherapy and combination therapy. J Eur Acad Dermatol Venereol. 2005; 19(1):21-9. DOI: 10.1111/j.1468-3083.2004.00988.x. View

Tosti A, Hay R, Arenas-Guzman R . Patients at risk of onychomycosis--risk factor identification and active prevention. J Eur Acad Dermatol Venereol. 2005; 19 Suppl 1:13-6. DOI: 10.1111/j.1468-3083.2005.01282.x. View

Tosti A, Iorizzo M, Piraccini B, Starace M . The nail in systemic diseases. Dermatol Clin. 2006; 24(3):341-7. DOI: 10.1016/j.det.2006.03.005. View

Gupta A, Ricci M . Diagnosing onychomycosis. Dermatol Clin. 2006; 24(3):365-9. DOI: 10.1016/j.det.2006.03.008. View

Scher R, Tavakkol A, Sigurgeirsson B, Hay R, Joseph W, Tosti A . Onychomycosis: diagnosis and definition of cure. J Am Acad Dermatol. 2007; 56(6):939-44. DOI: 10.1016/j.jaad.2006.12.019. View

Baran R, Sigurgeirsson B, de Berker D, Kaufmann R, Lecha M, Faergemann J . A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix.... Br J Dermatol. 2007; 157(1):149-57. DOI: 10.1111/j.1365-2133.2007.07974.x. View

10.

Shemer A, Nathansohn N, Kaplan B, Trau H . Toenail abnormalities and onychomycosis in chronic venous insufficiency of the legs: should we treat?. J Eur Acad Dermatol Venereol. 2008; 22(3):279-82. DOI: 10.1111/j.1468-3083.2007.02401.x. View

11.

Kaur R, Kashyap B, Bhalla P . Onychomycosis--epidemiology, diagnosis and management. Indian J Med Microbiol. 2008; 26(2):108-16. DOI: 10.4103/0255-0857.40522. View

12.

Gregoriou S, Argyriou G, Larios G, Rigopoulos D . Nail disorders and systemic disease: what the nails tell us. J Fam Pract. 2008; 57(8):509-14. View

13.

Seebacher C, Bouchara J, Mignon B . Updates on the epidemiology of dermatophyte infections. Mycopathologia. 2008; 166(5-6):335-52. DOI: 10.1007/s11046-008-9100-9. View

14.

Malay D, Yi S, Borowsky P, Downey M, Mlodzienski A . Efficacy of debridement alone versus debridement combined with topical antifungal nail lacquer for the treatment of pedal onychomycosis: a randomized, controlled trial. J Foot Ankle Surg. 2009; 48(3):294-308. DOI: 10.1053/j.jfas.2008.12.012. View

15.

de Berker D . Clinical practice. Fungal nail disease. N Engl J Med. 2009; 360(20):2108-16. DOI: 10.1056/NEJMcp0804878. View

16.

Mayser P, Freund V, Budihardja D . Toenail onychomycosis in diabetic patients: issues and management. Am J Clin Dermatol. 2009; 10(4):211-20. DOI: 10.2165/00128071-200910040-00001. View

17.

Bristow I, Spruce M . Fungal foot infection, cellulitis and diabetes: a review. Diabet Med. 2009; 26(5):548-51. DOI: 10.1111/j.1464-5491.2009.02722.x. View

18.

Welsh O, Vera-Cabrera L, Welsh E . Onychomycosis. Clin Dermatol. 2010; 28(2):151-9. DOI: 10.1016/j.clindermatol.2009.12.006. View

19.

Allevato M . Diseases mimicking onychomycosis. Clin Dermatol. 2010; 28(2):164-77. DOI: 10.1016/j.clindermatol.2009.12.001. View

20.

Thomas J, Jacobson G, Narkowicz C, Peterson G, Burnet H, Sharpe C . Toenail onychomycosis: an important global disease burden. J Clin Pharm Ther. 2010; 35(5):497-519. DOI: 10.1111/j.1365-2710.2009.01107.x. View